Scientists from the universities in Münster and Munich have discovered what precisely goes wrong in the body in the case of multiple sclerosis (MS). At the same time the neuroscientists were able to demonstrate that for MS, which occurs in bouts, there is a therapy which is tailor-made to eliminate the deficit.
The researchers involved are talking of a milestone: neuroimmunologists and neuropathologists from the universities in Münster and Munich have discovered what precisely goes wrong in the body in the case of multiple sclerosis (MS). Cells in the innate immune system – the natural killer cells (NK cells) – no longer fulfil their function with MS.
They cannot sufficiently keep in check the effector T cells, which are the cells that cause damage in the body in the case of MS. At the same time the neuroscientists were able to demonstrate that for MS, which occurs in bouts, there is a therapy which is tailor-made to eliminate the deficit – a blockade of the interleukin-2 receptor.
The drug used for this – Daclizumab – has just been recommended for approval by the European Medicines Agency EMA, so patients will soon be able to use it in their therapy. The effects of the new drug have already been demonstrated in clinical studies, in which the Münster neuroimmunologists were also involved. Their results, achieved in Collaborative Research Centre TR128 (“Multiple Sclerosis”), can be seen in the latest issue of the prestigious journal “Proceedings of the National Academy of Sciences”.
A healthy immune system functions like an efficient police check on traffic: anyone found speeding – in this case, autoreactive T lymphocytes – are singled out and punished. On the other hand, just the threat of a traffic fine is sufficient to prevent the majority of drivers from speeding.
This is how people posing a potential threat to others are held in check. In the case of multiple sclerosis, however, this check does not function properly. Autoreactive T cells cross the blood-brain barrier unhindered and pass into the brain, where they attack the nerve cells’ protective layer. Using the traffic image again: anyone speeding is not stopped and they cause serious accidents.
Project leaders Dr. Catharina Groß and Prof. Heinz Wiendl from the Department of General Neurology at Münster University Hospital demonstrated that cells from the body’s innate immune system – the NK cells – help decisively to keep dangerous autoreactive cells in check in healthy people. The researchers were even able to decipher the precise molecular mechanism which NK cells use to protect the immune system.
They also revealed that, in the case of MS, not only do the monitoring mechanisms of the immune system fail, but the harmful T cells also use tricks to evade any control on the part of the natural killer cells – just as if traffic offenders were to remove the number plates from their car so as not to be identified.
And one more thing the scientists showed was that there is a promising drug – Daclizumab, a monoclonal antibody – to counteract the interleukin-2 receptor and strengthen the immune-regulatory function of the NK cells. Support, so to speak, in monitoring the traffic. “We were able to demonstrate that Daclizumab not only reinforces the positive immune-regulatory function of the natural killer cells,“ says Dr. Groß, whose work was supported with funding from the German Research Foundation (DFG).
Together with her colleagues, one of the things she did was to analyse blood from patients with multiple sclerosis who had already been treated with the new substance. This substance, she says, leads to the harmful T cells again becoming more receptive to regulation by the NK cells. The European Medicines Agency EMA recommended at the end of April that the substance be approved after successful Phase II and Phase III studies on MS patients.
Research successes like this one need not only the expertise of neuroimmunologists in Münster, as Prof. Heinz Wiendl, who heads both the project and a working group, stresses. What progressed the project in particular was the collaboration with neuroscientists Prof. Reinhard Hohlfeld and Dr. Klaus Dornmair from Munich University and Prof. Tanja Kuhlmann from the Department of Neuropathology at Münster University. All these people work together as part of Collaborative Research Centre TR128 (“Multiple Sclerosis”), funded by the German Research Foundation. The Centre’s translational platform provided the blood and cerebrospinal fluid samples from patients which required for analysis.
Gross CC, Schulte-Mecklenbeck A, Rünzi A, Kuhlmann T, Posevitz-Fejfár A, Schwab N, Schneider-Hohendorf T, Herich A, Held K, KonjeviM, Hartwig M, Dornmair K, Hohlfeld R, Ziemssen T, Klotz L, Meuth SG, Wiendl H, Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation. PNAS 2016; published ahead of print May 9, 2016, doi:10.1073/pnas.1524924113
Dr. Thomas Bauer
http://www.pnas.org/content/early/2016/05/04/1524924113.abstract?sid=50ecc138-88... Original publication (PNAS)
Dr. Christina Heimken | idw - Informationsdienst Wissenschaft
Finnish research group discovers a new immune system regulator
23.02.2018 | University of Turku
Minimising risks of transplants
22.02.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.
In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...
A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.
By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...
Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
23.02.2018 | Physics and Astronomy
23.02.2018 | Health and Medicine
23.02.2018 | Physics and Astronomy